Acetylsalicylic acid Completed Phase 3 Trials for Cerebrovascular Accident Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT00311402JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme